Condition: Hernia, Ventral · Hernia, Inguinal · Sponsor: Tela Bio Inc
This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
This description comes directly from the study's public registry record.
Melissa LaMantia · 757-761-4922 · mlamantia@telabio.com
Danielle Campbell · 717-676-2589 · dcampbell@telabio.com
Always discuss trial participation with your own doctor first.
| University of South Alabama | Mobile, Alabama, United States | Recruiting |
| SurgOne | Denver, Colorado, United States | Active Not Recruiting |
| GenesisCare | Destin, Florida, United States | Terminated |
| Surgical Healing Arts Center | Fort Myers, Florida, United States | Terminated |
| St. Luke's Hospital | Overland Park, Kansas, United States | Active Not Recruiting |
| University of Louisville | Louisville, Kentucky, United States | Recruiting |
| Munson Healthcare | Traverse City, Michigan, United States | Recruiting |
| St. Francis Hospital | Roslyn, New York, United States | Withdrawn |
| Mohawk Valley Health System | Utica, New York, United States | Withdrawn |
| Houston Methodist | Houston, Texas, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04779918